Effect of Viewing Conditions on Fixation Eye Movements and Eye Alignment in Amblyopia.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
12
3
2022
Statut:
ppublish
Résumé
Patients with amblyopia are known to have fixation instability, which arises from alteration of physiologic fixation eye movements (FEMs) and nystagmus. We assessed the effects of monocular, binocular, and dichoptic viewing on FEMs and eye alignment in patients with and without fusion maldevelopment nystagmus (FMN). Thirty-four patients with amblyopia and seven healthy controls were recruited for this study. Eye movements were recorded using infrared video-oculography during (1) fellow eye viewing (FEV), (2) amblyopic eye viewing (AEV), (3) both eye viewing (BEV), and (4) dichoptic viewing (DcV) at varying fellow eye (FE) contrasts. The patients were classified per the clinical type of amblyopia and FEM waveforms into those without nystagmus, those with nystagmus with and without FMN. Fixational saccades and intersaccadic drifts, quick and slow phases of nystagmus, and bivariate contour ellipse area were analyzed in the FE and amblyopic eye (AE). We found that FEMs are differentially affected with increased amplitude of quick phases of FMN observed during AEV than BEV and during DcV at lower FE contrasts. Increased fixation instability was seen in anisometropic patients at lower FE contrasts. Incomitance of eye misalignment was seen with the greatest increase during FEV. Strabismic/mixed amblyopia patients without FMN were more likely to demonstrate a fixation switch where the AE attends to the target during DcV than patients with FMN. Our findings suggest that FEM abnormalities modulate with different viewing conditions as used in various amblyopia therapies. Increased FEM abnormalities could affect the visual function deficits and may have treatment implications.
Identifiants
pubmed: 35212720
pii: 2778609
doi: 10.1167/iovs.63.2.33
pmc: PMC8883146
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Subventions
Organisme : NEI NIH HHS
ID : T32 EY024236
Pays : United States
Références
Vision Res. 2008 Dec;48(28):2775-84
pubmed: 18809424
Vis Neurosci. 1997 Jul-Aug;14(4):681-9
pubmed: 9278997
Ophthalmic Physiol Opt. 2014 Mar;34(2):214-25
pubmed: 24495165
Sci Rep. 2021 Jan 13;11(1):1217
pubmed: 33441575
Science. 1965 Dec 10;150(3702):1459-60
pubmed: 5855207
Science. 2009 Feb 13;323(5916):940-3
pubmed: 19213919
PLoS One. 2020 Aug 13;15(8):e0237346
pubmed: 32790721
Invest Ophthalmol Vis Sci. 2008 May;49(5):1872-8
pubmed: 18223249
J Neurosci. 2012 Jul 4;32(27):9194-204
pubmed: 22764228
Neuroscience. 2008 Oct 2;156(2):403-11
pubmed: 18708128
Curr Biol. 2013 Sep 9;23(17):1691-5
pubmed: 23954428
J Neurophysiol. 1972 Nov;35(6):915-24
pubmed: 4631839
Ther Adv Ophthalmol. 2019 Jun 19;11:2515841419857379
pubmed: 31259304
Eye Brain. 2021 Apr 28;13:99-109
pubmed: 33953627
Am J Ophthalmol. 2020 Oct;218:173-181
pubmed: 32511967
J Neurosci. 1983 Dec;3(12):2563-86
pubmed: 6655500
Invest Ophthalmol Vis Sci. 2011 Jun 13;52(7):4169-76
pubmed: 21447685
Ann N Y Acad Sci. 2011 Sep;1233:107-16
pubmed: 21950983
J Vis. 2005 Aug 17;5(7):632-9
pubmed: 16231998
Psychol Sci. 2004 Jun;15(6):431-6
pubmed: 15147499
Can J Ophthalmol. 2013 Oct;48(5):394-9
pubmed: 24093186
J Vis. 2008 Dec 18;8(14):21.1-18
pubmed: 19146322
Front Integr Neurosci. 2014 Jul 07;8:52
pubmed: 25071480
J Neurosci. 1987 May;7(5):1340-51
pubmed: 3572484
Arch Ophthalmol. 2005 Apr;123(4):557-8
pubmed: 15824233
J AAPOS. 2002 Aug;6(4):201-2
pubmed: 12185342
Strabismus. 2016 Jun;24(2):45-50
pubmed: 27220683
Vis Neurosci. 2018 Jan;35:E016
pubmed: 29905122
Ophthalmology. 2004 Dec;111(12):2265-70
pubmed: 15582084
Am J Ophthalmol. 2018 Feb;186:104-115
pubmed: 29196184
J AAPOS. 2005 Feb;9(1):37-47
pubmed: 15729279
JAMA Ophthalmol. 2015 Apr;133(4):479-80
pubmed: 25611129
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5743-5753
pubmed: 29114840
Ophthalmology. 1993 Oct;100(10):1488-97
pubmed: 8414409
Curr Opin Neurobiol. 1999 Aug;9(4):480-6
pubmed: 10448162
Doc Ophthalmol. 1989 Aug;72(3-4):375-84
pubmed: 2625098
J AAPOS. 2019 Jun;23(3):160.e1-160.e5
pubmed: 31103562
J Neuroophthalmol. 2010 Sep;30(3):276-83
pubmed: 20818206
J Neurosci. 1987 May;7(5):1327-39
pubmed: 3033169
Vision Res. 1972 Nov;12(11):1795-808
pubmed: 4627952
PLoS One. 2016 Mar 01;11(3):e0149953
pubmed: 26930079
Front Neurol. 2018 Mar 13;9:144
pubmed: 29593642
Ophthalmology. 2006 Nov;113(11):2097-100
pubmed: 17074568
Exp Brain Res. 1990;79(3):615-22
pubmed: 2340878
Prog Brain Res. 2019;249:235-248
pubmed: 31325983
J Eye Mov Res. 2019 Jul 5;12(6):
pubmed: 33828757
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3805-17
pubmed: 11053280
Am J Ophthalmol. 1987 Jan 15;103(1):87-9
pubmed: 3799793
Nature. 1982 Oct 14;299(5884):583-91
pubmed: 6811951
JAMA Ophthalmol. 2018 Feb 1;136(2):172-181
pubmed: 29302694
J AAPOS. 2013 Jun;17(3):287-90
pubmed: 23791411
Optom Vis Sci. 2013 Jan;90(1):45-56
pubmed: 23238260
Nat Neurosci. 2000 Mar;3(3):251-8
pubmed: 10700257
J Vis. 2019 Apr 1;19(4):9
pubmed: 30943531
Vision Res. 2005 Mar;45(6):721-30
pubmed: 15639499
Prog Brain Res. 2006;154:151-76
pubmed: 17010709
PeerJ. 2013 Aug 01;1:e119
pubmed: 23940832
Vision Res. 1979;19(12):1359-67
pubmed: 532102
J Neurosci. 1987 May;7(5):1318-26
pubmed: 3572483
J AAPOS. 2000 Jun;4(3):168-74
pubmed: 10849394
Arch Ophthalmol. 1979 Oct;97(10):1877-85
pubmed: 485910
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2531-5
pubmed: 25678690
PLoS One. 2017 Apr 13;12(4):e0175295
pubmed: 28406944
PLoS One. 2015 Jun 02;10(6):e0128428
pubmed: 26035820
JAMA Ophthalmol. 2016 Jan;134(1):63-9
pubmed: 26562632
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4506-4517
pubmed: 30208418
J Neurosci. 1998 Aug 15;18(16):6411-24
pubmed: 9698332
Vision Res. 2003 Apr;43(9):1035-45
pubmed: 12676246
Vision Res. 2015 Sep;114:87-99
pubmed: 25668775
J Comp Neurol. 2004 Jun 21;474(2):261-75
pubmed: 15164426
Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5386-94
pubmed: 22789926
Invest Ophthalmol Vis Sci. 2013 Mar 19;54(3):1998-2003
pubmed: 23372053
JAMA Ophthalmol. 2014 Jul;132(7):799-805
pubmed: 24789375
Nat Neurosci. 2010 Dec;13(12):1549-53
pubmed: 21037583
Invest Ophthalmol Vis Sci. 1981 Feb;20(2):257-63
pubmed: 7461928
Ann N Y Acad Sci. 2002 Apr;956:346-60
pubmed: 11960818
Arch Ophthalmol. 1979 Mar;97(3):462-9
pubmed: 420633
Invest Ophthalmol Vis Sci. 1990 May;31(5):968-76
pubmed: 2335458
PLoS One. 2013;8(2):e56556
pubmed: 23441203
Strabismus. 1996;4(4):171-7
pubmed: 21314368
Nat Rev Neurosci. 2013 Feb;14(2):83-96
pubmed: 23329159
J Comp Neurol. 1997 Nov 10;388(1):32-46
pubmed: 9364237
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5408-5416
pubmed: 30452594
Restor Neurol Neurosci. 2012;30(6):445-62
pubmed: 23001901
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1087-95
pubmed: 26968739
J Vis. 2008 Nov 04;8(14):15.1-9
pubmed: 19146316
Strabismus. 2006 Mar;14(1):3-10
pubmed: 16513565
Hum Neurobiol. 1982;1(2):97-109
pubmed: 6764462
Vision Res. 2008 Jul;48(15):1625-40
pubmed: 18547600
Eye (Lond). 1996;10 ( Pt 2):250-8
pubmed: 8776456
Br J Ophthalmol. 2018 Feb;102(2):253-259
pubmed: 28698242
Ophthalmology. 2019 Mar;126(3):456-466
pubmed: 30352226
J Vis. 2008 Aug 06;8(11):5.1-23
pubmed: 18831599